Cover ImageSALE
市場調查報告書

OTC藥及補充品市場:類別,劑型,產品,各流通管道 - 全球機會分析及產業預測

Over the Counter (OTC) Drugs & Dietary Supplements Market by Category, Dosage Form, Product, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2017-2023

出版商 Allied Market Research 商品編碼 563338
出版日期 內容資訊 英文 220 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
OTC藥及補充品市場:類別,劑型,產品,各流通管道 - 全球機會分析及產業預測 Over the Counter (OTC) Drugs & Dietary Supplements Market by Category, Dosage Form, Product, and Distribution Channel - Global Opportunity Analysis and Industry Forecast, 2017-2023
出版日期: 2017年08月01日 內容資訊: 英文 220 Pages
簡介

本報告提供全球OTC藥及補充品市場相關調查,彙整市場各類別,各劑型,各產品,各流通管道,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 相關法規
  • 市場佔有率分析
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 各類別市場

  • 概要
  • 維他命·補充品
  • 咳嗽·感冒用產品
  • 止痛藥
  • 腸胃用產品
  • 睡眠補助
  • OTC產品
  • WART REMOVERS
  • 口腔保健
  • 眼科產品
  • 植物產品
  • 解酸劑
  • 戒煙產品
  • 女性護理用品
  • 其他

第5章 各劑型市場

  • 概要
  • 錠劑
  • 硬膠囊
  • 軟膏
  • 軟體膠囊
  • 液體
  • 其他

第6章 各產品類型市場

  • 概要
  • 品牌藥
  • 學名藥

第7章 各流通管道市場

  • 概要
  • 藥局
  • 維他命·保健食品店
  • 線上藥局
  • 食品店
  • 其他

第8章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第9章 企業簡介

目錄
Product Code: LI 172695

Over the counter (OTC) drugs are non-prescription medicines, which are sold directly to consumers without any prescription from doctors and other healthcare professionals. The OTC drugs are regulated by governmental bodies to ensure that the ingredients used are safe and effective for use without a physician's supervision. These drugs are regulated by active pharmaceutical ingredients (APIs) not final product. Dietary supplements are intended to provide nutrients to increase the quantity of consumption or provide non-nutrient chemicals that have biologically beneficial effects to users. These supplements are available across all distribution channels such as pharmacies, grocery stores, shopping marts, online pharmacies, and other retailers. The global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach at $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023.

The global over the counter (OTC) drugs & dietary supplements market is driven by improvement in lifestyle & ageing of baby boomers, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. In addition, increase in trend of self-directed consumers and self-medication for the treatment of primary health conditions have fueled the market growth. However, stringent regulations by FDA and other governing bodies related to the safety & efficacy of OTC medications have delayed the approval restricting the market growth. Furthermore, minors, i.e. individuals under 18 years of age, are restricted to buy certain medications, which consist addictive chemicals, impeding the market growth.

The global over the counter (OTC) drugs & dietary supplements market is segmented based on category, dosage form, product, distribution channel, and geography. Based on category, it is divided into vitamin and dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, botanicals, antacids, smoking cessation products, feminine care, and others. On the basis of dosage form, it is classified into tablets, hard capsules, powders, ointments, soft capsules, liquids, and others. Based on product, it is categorized into branded and generic drugs. Based on distribution channel, it is divided into pharmacies, grocery stores, vitamin & health food stores, online pharmacies, and others.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the high consumer base especially for dietary supplements as consumers are more health conscious. However, Asia-Pacific is expected to emerge as a lucrative area for market players, due to increase in disposable income along with a shift in the consumer preference towards self-medication, improvement in healthcare facilities, and rapid development of economic conditions.

KEY BENEFITS FOR STAKEHOLDERS:

  • The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analyses of factors that drive and restrict the market growth are provided in the report.
  • Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps in understanding the trending products across the various regions.
  • Key market players and their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS:

By Category

  • Vitamin & Dietary Supplements
  • Cough & Cold Products
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Otic Products
  • Wart Removers
  • Mouth Care Products
  • Ophthalmic Products
  • Botanicals
  • Antacids
  • Smoking Cessation Products
  • Feminine Care
  • Others

By Dosage Form

  • Tablets
  • Hard Capsules
  • Powders
  • Ointments
  • Soft Capsules
  • Liquids
  • Others

By Product

  • Branded Drugs
  • Generic Drugs

By Distribution Channel

  • Pharmacies
  • Grocery Stores
  • Vitamin & Health Food Stores
  • Online Pharmacy
  • Others

By Geography

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Argentina
  • Turkey
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

KEY PLAYERS PROFILED:

  • Pfizer Inc.
  • Novartis International AG.
  • Roche Holding AG
  • Merck & Co., Inc.
  • Sanofi S.A
  • Johnson & Johnson
  • Gilead Sciences
  • GlaxoSmithKline plc.
  • Bayer Healthcare AG
  • AstraZeneca plc.
  • The other players in the value chain include (profiles not included in the report)
  • Alacer Corp
  • Alcon Inc.
  • Alfresa Pharma Corporation
  • Alkalon A/S
  • Alliance Healthcare
  • Allergan, Plc.
  • Reckitt Benckiser Plc.
  • Bausch & Lomb
  • AbbVie Inc.
  • The Colgate-Palmolive Company

Table of Contents

CHAPTER 1 INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. KEY BENEFITS
  • 1.3. KEY MARKET SEGMENTS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

  • 2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top investment pockets
    • 3.2.2. Top winning strategies
  • 3.3. PORTERS FIVE FORCES ANALYSIS
  • 3.4. REGULATORY FRAMEWORK
  • 3.5. MARKET SHARE ANALYSIS, 2016
  • 3.6. MARKET DYNAMICS
    • 3.6.1. Drivers
      • 3.6.1.1. Improvement in lifestyle and age related diseases
      • 3.6.1.2. The rise in self-directed consumer
      • 3.6.1.3. Growing awareness regarding general health concerns and advancements in healthcare industry
    • 3.6.2. Restraints
      • 3.6.2.1. Stringent regulatory policies by governing bodies
      • 3.6.2.2. Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs
    • 3.6.3. Opportunities
      • 3.6.3.1. Increasing R&D expenditure and funding from the public & private sector

CHAPTER 4 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. VITAMIN AND DIETARY SUPPLEMENTS (VDS)
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. COUGH & COLD PRODUCTS
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast
  • 4.4. ANALGESICS
    • 4.4.1. Key market trends
    • 4.4.2. Growth factors and opportunities
    • 4.4.3. Market size and forecast
  • 4.5. GASTROINTESTINAL PRODUCTS
    • 4.5.1. Key market trends
    • 4.5.2. Growth factors and opportunities
    • 4.5.3. Market size and forecast
  • 4.6. SLEEP AIDS
    • 4.6.1. Key market trends
    • 4.6.2. Growth factors and opportunities
    • 4.6.3. Market size and forecast
  • 4.7. OTIC PRODUCTS
    • 4.7.1. Key market trends
    • 4.7.2. Growth factors and opportunities
    • 4.7.3. Market size and forecast
  • 4.8. WART REMOVERS
    • 4.8.1. Key market trends
    • 4.8.2. Growth factors and opportunities
    • 4.8.3. Market size and forecast
  • 4.9. MOUTH CARE PRODUCTS
    • 4.9.1. Key market trends
    • 4.9.2. Growth factors and opportunities
    • 4.9.3. Market size and forecast
  • 4.10. OPHTHALMIC PRODUCTS
    • 4.10.1. Key market trends
    • 4.10.2. Growth factors and opportunities
    • 4.10.3. Market size and forecast
  • 4.11. BOTANICALS
    • 4.11.1. Key market trends
    • 4.11.2. Growth factors and opportunities
    • 4.11.3. Market size and forecast
  • 4.12. ANTACIDS
    • 4.12.1. Key market trends
    • 4.12.2. Growth factors and opportunities
    • 4.12.3. Market size and forecast
  • 4.13. SMOKING CESSATION PRODUCTS
    • 4.13.1. Key market trends
    • 4.13.2. Growth factors and opportunities
    • 4.13.3. Market size and forecast
  • 4.14. FEMININE CARE
    • 4.14.1. Key market trends
    • 4.14.2. Growth factors and opportunities
    • 4.14.3. Market size and forecast
  • 4.15. OTHERS
    • 4.15.1. Key market trends
    • 4.15.2. Growth factors and opportunities
    • 4.15.3. Market size and forecast

CHAPTER 5 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. TABLETS
    • 5.2.1. Market size and forecast
  • 5.3. HARD CAPSULES
    • 5.3.1. Market size and forecast
  • 5.4. POWDERS
    • 5.4.1. Market size and forecast
  • 5.5. OINTMENTS
    • 5.5.1. Market size and forecast
  • 5.6. SOFT CAPSULES
    • 5.6.1. Market size and forecast
  • 5.7. LIQUIDS
    • 5.7.1. Market size and forecast
  • 5.8. OTHERS
    • 5.8.1. Market size and forecast

CHAPTER 6 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS, BY PRODUCT TYPE

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. BRANDED
    • 6.2.1. Market size and forecast
  • 6.3. GENERICS
    • 6.3.1. Market size and forecast

CHAPTER 7 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast
  • 7.2. PHARMACIES
    • 7.2.1. Market size and forecast
  • 7.3. VITAMIN AND HEALTH FOOD STORES
    • 7.3.1. Market size and forecast
  • 7.4. ONLINE PHARMACY
    • 7.4.1. Market size and forecast
  • 7.5. GROCERY STORES
    • 7.5.1. Market size and forecast
  • 7.6. OTHERS
    • 7.6.1. Market size and forecast

CHAPTER 8 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY GEOGRAPHY

  • 8.1. OVERVIEW
    • 8.1.1. Market size and forecast
  • 8.2. NORTH AMERICA
    • 8.2.1. Key market trends
    • 8.2.2. Key growth factors and opportunities
    • 8.2.3. Market size and forecast
      • 8.2.3.1. U.S. market size and forecast
      • 8.2.3.2. Mexico market size and forecast
      • 8.2.3.3. Canada market size and forecast
  • 8.3. EUROPE
    • 8.3.1. Key market trends
    • 8.3.2. Key growth factors and opportunities
    • 8.3.3. Market size and forecast
      • 8.3.3.1. UK market size and forecast
      • 8.3.3.2. France market size and forecast
      • 8.3.3.3. Germany market size and forecast
      • 8.3.3.4. Italy market size and forecast
      • 8.3.3.5. Spain market size and forecast
      • 8.3.3.6. Rest of Europe market size and forecast
  • 8.4. ASIA-PACIFIC
    • 8.4.1. Key market trends
    • 8.4.2. Key growth factors and opportunities
    • 8.4.3. Market size and forecast
      • 8.4.3.1. Japan market size and forecast
      • 8.4.3.2. China market size and forecast
      • 8.4.3.3. India market size and forecast
      • 8.4.3.4. Australia market size and forecast
      • 8.4.3.5. Rest of Asia-Pacific market size and forecast
  • 8.5. LAMEA
    • 8.5.1. Key market trends
    • 8.5.2. Key growth factors and opportunities
    • 8.5.3. Market size and forecast
      • 8.5.3.1. Brazil market size and forecast
      • 8.5.3.2. Argentina market size and forecast
      • 8.5.3.3. Turkey market size and forecast
      • 8.5.3.4. Saudi Arabia market size and forecast
      • 8.5.3.5. South Africa market size and forecast
      • 8.5.3.6. Rest of LAMEA market size and forecast

CHAPTER 9 COMPANY PROFILES

  • 9.1. PFIZER INC.
    • 9.1.1. Company overview
    • 9.1.2. Company snapshot
    • 9.1.3. Operating business segments
    • 9.1.4. Business performance
    • 9.1.5. Key strategic moves and developments
  • 9.2. NOVARTIS INTERNATIONAL AG
    • 9.2.1. Company overview
    • 9.2.2. Company snapshot
    • 9.2.3. Operating business segments
    • 9.2.4. Business performance
    • 9.2.5. Key strategic moves and developments
  • 9.3. ROCHE HOLDING AG
    • 9.3.1. Company overview
    • 9.3.2. Company snapshot
    • 9.3.3. Operating business segments
    • 9.3.4. Business performance
    • 9.3.5. Key strategic moves and developments
  • 9.4. MERCK & CO., INC.
    • 9.4.1. Company overview
    • 9.4.2. Company snapshot
    • 9.4.3. Operating business segments
    • 9.4.4. Business performance
    • 9.4.5. Key strategic moves and developments
  • 9.5. SANOFI S.A
    • 9.5.1. Company overview
    • 9.5.2. Company snapshot
    • 9.5.3. Operating business segments
    • 9.5.4. Business performance
    • 9.5.5. Key strategic moves and developments
  • 9.6. JOHNSON & JOHNSON
    • 9.6.1. Company overview
    • 9.6.2. Company snapshot
    • 9.6.3. Operating business segments
    • 9.6.4. Business performance
    • 9.6.5. Key strategic moves and developments
  • 9.7. GILEAD SCIENCES
    • 9.7.1. Company overview
    • 9.7.2. Company snapshot
    • 9.7.3. Operating business segments
    • 9.7.4. Business performance
    • 9.7.5. Key strategic moves and developments
  • 9.8. GLAXOSMITHKLINE PLC
    • 9.8.1. Company overview
    • 9.8.2. Company snapshot
    • 9.8.3. Operating business segments
    • 9.8.4. Business performance
    • 9.8.5. Key strategic moves and developments
  • 9.9. BAYER HEALTHCARE AG
    • 9.9.1. Company overview
    • 9.9.2. Company snapshot
    • 9.9.3. Operating business segments
    • 9.9.4. Business performance
    • 9.9.5. Key strategic moves and developments
  • 9.10. ASTRAZENECA PLC
    • 9.10.1. Company overview
    • 9.10.2. Company snapshot
    • 9.10.3. Operating business segments
    • 9.10.4. Business performance
    • 9.10.5. Key strategic moves and developments
Back to Top